Healthcare >> CEO Interviews >> October 26, 2004
ARTHUR S. PRZYBL joined Akorn, Inc., in August 2001 and was promoted to
Chief Executive Officer in September 2002. He is a seasoned healthcare
executive in a career spanning over 25 years. Prior to joining Akorn,
Mr. Przybyl served as President and Chief Executive Officer for Hearing
Innovations Inc., an innovative, startup developer of medical devices
for the profoundly deaf and tinnitus markets. Previous to that, he
served as President and Chief Operating Officer for Bioject, Inc., a
NASDAQ company specializing in needle-free technology. Mr. Przybyl also
helped engineer a successful turnaround at International Medication
Systems Ltd. as Senior Vice President, Sales and Marketing for this
generic pharmaceutical manufacturer. Mr. Przybyl has held several sales
and marketing positions with generic pharmaceutical companies including
a six-year career with LyphoMed, Inc. Profile
operations.
Mr. Przybyl: Akorn was founded in 1971, as a distributor of ophthalmic
products. Akorn is now a specialty
